Periodic Reporting for period 1 - MYCureX (FIRST-IN-CLASS MYC INHIBITOR: THE MAKING OF A BREAKTHROUGH CANCER THERAPY)

Cancers are a leading cause of mortality, accounting for nearly 10 million (M) annual deaths worldwide Personalized medicine and immunotherapy have improved the prognosis for several patients, yet their applicability remains limited, often targeting redundant cell functions...